JSR Life Sciences, LLC ("JSR") today announced that Similis Bio ("Similis"), its business unit focused on biosimilar development, has announced plans to enter into a partnership with Novel351k to co-develop
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has announced it has entered into an agreement to acquire the IndivuServ business unit of Indivumed GmbH.
/PRNewswire/ The "Chromatography Resin - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com s offering. Amid the COVID-19.